Mindray, China-based developer and provider of advanced medical devices and solutions, has recently launched its first w...
China-based Tianlong launched its new product Panall 8000 All-in-one Molecular Diagnosis System, at Medlab Middle East 2...
The Hong Kong Polytechnic University (PolyU) and The Education University of Hong Kong (EdUHK) have signed a Memorandum ...
China-based Taimei Technology, a digital cooperation platform for the life science industry, has announced the open...
Zhongchao Inc. has obtained the general distribution rights in Mainland China for anti-influenza drug from Indian pharma...
Chinese startup NERVTEX's MoDAS (Movement Dysfunction Assessment Software) system, which is a First-in-Class Artificial ...
CARsgen Therapeutics Holdings, a biopharmaceutical startup based in the US and China, has announced collaboration agreem...
South Korea's Daewoong Pharmaceutical has secured an exclusive licensing agreement with CS Pharmaceuticals, a UK based m...
Shanghai Duoning Biotechnology Co. has signed an agreement on the Transfer of the Right to Use State-owned Construc...
PanopticAI, Hong Kong's leading health and wellness monitoring startup, has announced a deal closing on a seed...
GenScript ProBio, a subsidiary of GenScript Biotech Corporation, has announced its Series C round of financing of n...
ReLive Biotechnologies, founded in 2021, has completed the acquisition of all operating assets of Germany-listed bi...
Hong Kong Science and Technology Parks (HKSTP) Corporation has announced a strategic collaboration with Roche, one of th...
Japan-based Chiome Bioscience has agreed to terminate the License Agreement for anti-TROP-2 antibody ( LIV-20...
Asieris Pharmaceuticals, a China-based biopharma company specialising in discovering, developing and commercialising inn...
The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine), Microbiota I-Center (MagIC), and Hong Kong...
Amcor, a Switzerland-headquartered firm that develops and produces responsible packaging solutions, has entered into an ...
Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...
